Burrows v. Secretary of Health and Human Services

CourtUnited States Court of Federal Claims
DecidedSeptember 11, 2025
Docket23-0925V
StatusUnpublished

This text of Burrows v. Secretary of Health and Human Services (Burrows v. Secretary of Health and Human Services) is published on Counsel Stack Legal Research, covering United States Court of Federal Claims primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Burrows v. Secretary of Health and Human Services, (uscfc 2025).

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 23-925V

JAY M. BURROWS, Chief Special Master Corcoran

Petitioner, v. Filed: August 5, 2025

SECRETARY OF HEALTH AND HUMAN SERVICES,

Respondent.

Jimmy A. Zgheib, Zgheib Sayad, P.C., White Plains, NY, for Petitioner.

Mary Novakovic, U.S. Department of Justice, Washington, DC, for Respondent.

DISMISSAL DECISION 1

On June 20, 2023, Jay M. Burrows filed a petition for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq. 2 (the “Vaccine Act”), alleging that he suffered a right-sided Table shoulder injury related to vaccine administration (“SIRVA”) as a result of an influenza (“flu”) vaccine administered to him on December 31, 2020. 3 Pet. at 1, ECF No. 1. The case was assigned to the Special Processing Unit of the Office of Special Masters.

Based on a review of the evidence in this case, I find that Petitioner has failed to preponderantly demonstrate a critical SIRVA element: that the onset of his shoulder injury

1 Because this Decision contains a reasoned explanation for the action taken in this case, it must be made

publicly accessible and will be posted on the United States Court of Federal Claims' website, and/or at https://www.govinfo.gov/app/collection/uscourts/national/cofc, in accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government Services). This means the Decision will be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such material from public access.

2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease

of citation, all section references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2018).

3 In the alternative, Petitioner alleges that his flu vaccine was the cause-in-fact of his shoulder injury. Pet.

at 5. occurred within the Table’s 48-hour window. And because the same facts would support no other kind of claim, the petition is appropriately dismissed.

I. Relevant Procedural History and the Parties’ Arguments

Respondent filed his Rule 4(c) Report in defense of this claim on April 5, 2024, arguing that the medical records do not support the conclusion that the onset of Petitioner’s pain occurred within 48 hours of vaccination. ECF No. 15 at 7-9. Petitioner in response filed a Motion for Finding of Fact on May 1, 2024, arguing that he can establish proper onset. ECF No. 16 at 7. Respondent filed his Response 4 to Petitioner’s Motion on June 28, 2024, maintaining his previous arguments 5 and adding that Petitioner’s Motion “relies heavily on personal declarations, highlights records generated several months or years after the vaccination at issue, and attempts to explain away the lack of any documented symptoms in the contemporaneous records.” ECF No. 20 at 1. Petitioner filed a Reply on July 10, 2024, stating that “there is no outstanding evidence that would impact the determination of onset” and further addressing Respondent’s arguments. ECF No. 21. The onset dispute is now ripe for consideration.

4 Prior to filing his Response to Petitioner’s Motion, Respondent filed a Motion to Suspend the Response Deadline. ECF No. 17. In support of his request, Respondent argued Petitioner’s Motion was premature, as Respondent requested (but Petitioner had not filed) additional records in his Rule 4(c) report, including text messages between Petitioner and his PCP “that are potentially relevant to [P]etitioner’s Vaccine Act Claim.” Id. at 1. Specifically, Respondent requested “all messages relating to the vaccination or [P]etitioner’s alleged injury” and for “clarification on whether [P]etitioner was the recipient of the text message in Exhibit 5.” Respondent’s Report at 5, n.1. Petitioner filed a Response to Respondent’s Motion to Suspend, stating that he “informed Respondent that the only relevant message was from Dr. Huizenga on August 12, 2021[,] and is filed at Exhibit 5[.]” ECF No. 18. Petitioner further informed Respondent that Petitioner was the recipient of that message, Dr. Huizenga corroborated the message contents in Exhibit 9, there are no additional messages related to Petitioner’s vaccination, and “there is no additional information responsive to Respondent’s request.” Id. In light of Petitioner’s representations that no additional records exist, the assigned OSM staff attorney, acting on my behalf, contacted the parties via informal email communication, stating that the record appears sufficient to make a determination as to onset. The assigned OSM staff attorney confirmed that an affidavit regarding the representations made in Petitioner’s Response to the Motion to Suspend was not required, and I ordered a substantive Response from Respondent. See ECF No. 19; see also 42 U.S.C. § 300aa-11(c)(3) (requiring an affidavit if a petitioner is contending that outstanding records exist but are ultimately unavailable and thus explaining the records’ unavailability).

5 In addition to his arguments regarding Table onset, Respondent also argued that Petitioner cannot establish the Vaccine Act’s statutory severity requirement, as his “first medical visit for his right shoulder was almost one year after vaccination on December 14, 2021.” Response at 3, ECF No. 20 (citing Ex. 4 at 182; 42 U.S.C. § 300aa-11(c)(1)(D)(i)). Respondent also argued Petitioner has failed to establish a causation-in-fact shoulder injury claim. Id. at 9-10.

2 II. Authority

Pursuant to Vaccine Act Section 13(a)(1)(A), a petitioner must prove, by a preponderance of the evidence, the matters required in the petition by Vaccine Act Section 11(c)(1).

A vaccine recipient shall be considered to have suffered SIRVA if such recipient manifests all of the following:

(i) No history of pain, inflammation or dysfunction of the affected shoulder prior to intramuscular vaccine administration that would explain the alleged signs, symptoms, examination findings, and/or diagnostic studies occurring after vaccine injection;

(ii) Pain occurs within the specified time-frame;

(iii) Pain and reduced range of motion are limited to the shoulder in which the intramuscular vaccine was administered; and

(iv) No other condition or abnormality is present that would explain the patient's symptoms (e.g. NCS/EMG or clinical evidence of radiculopathy, brachial neuritis, mononeuropathies, or any other neuropathy).

42 C.F.R. § 100.3.

If, however, a petitioner suffered an injury that either is not listed in the Table or did not occur within the prescribed time frame, he must prove that the administered vaccine caused his injury to receive Program compensation. § 11(c)(1)(C)(ii) and (iii).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Burrows v. Secretary of Health and Human Services, Counsel Stack Legal Research, https://law.counselstack.com/opinion/burrows-v-secretary-of-health-and-human-services-uscfc-2025.